Regulation of signaling events involved in the pathophysiology of neovascular AMD

Molecular Vision

Volumn 22, Issue , 2016, Pages 189-202

  Wang, Haibo ^a   Elizabeth Hartnett, M ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATASE; GUANOSINE TRIPHOSPHATE; RAC1 PROTEIN; RAP1 PROTEIN; VASCULOTROPIN;

AGE RELATED MACULAR DEGENERATION; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL INTERACTION; CELL MIGRATION; CELLS BY BODY ANATOMY; CHOROIDAL EPITHELIAL CELL; DISEASE ACTIVITY; DISEASE ASSOCIATION; EPITHELIUM CELL; HUMAN; MOLECULAR PATHOLOGY; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN BINDING; SIGNAL TRANSDUCTION; CHOROID; ENDOTHELIUM CELL; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINAL PIGMENT EPITHELIUM; SUBRETINAL NEOVASCULARIZATION; WET MACULAR DEGENERATION;

CHOROID; CHOROIDAL NEOVASCULARIZATION; ENDOTHELIAL CELLS; HUMANS; RAC1 GTP-BINDING PROTEIN; RAP1 GTP-BINDING PROTEINS; RETINAL PIGMENT EPITHELIUM; SIGNAL TRANSDUCTION; WET MACULAR DEGENERATION;

EID: 84959537002     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (115)

1. Bird AC. Therapeutic targets in age-related macular disease. J Clin Invest 2010; 120:3033-41. [PMID: 20811159].
2. Green WR, Enger C. Age-related macular degeneration histopathologic studies. The 1992 Lorenz E. Zimmerman Lecture. Ophthalmology 1993; 100:1519-35. [PMID: 7692366].
3. Yannuzzi LA, Sorenson J, Spaide RF, Lipson B. Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina 1990; 10:1-8. [PMID: 1693009].
4. Dansingani KK, Balaratnasingam C, Naysan J, Freund KB. En face imaging of pachychoroid spectrum disorders with swept-source optical coherence tomography. Retina 2015; [PMID: 26335436].
5. Hartnett ME, Weiter JJ, Garsd A, Jalkh AE. Classification of retinal pigment epithelial detachments associated with drusen. Graefes Arch Clin Exp Ophthalmol 1992; 230:11-9. [PMID: 1547961].
6. Poliner LS, Olk RJ, Burgess D, Gordon ME. Natural history of retinal pigment epithelial detachments in age-related macular degeneration. Ophthalmology 1986; 93:543-51. [PMID: 2425324].
7. Seddon JM, Ajani UA, Sperduto RD, Hiller R, Blair N, Burton TC, Farber MD, Gragoudas ES, Haller J, Miller DT, Yannuzzi LA, Willett W. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA 1994; 272:1413-20. [PMID: 7933422].
8. Green WR, Key SN 3rd. Senile macular degeneration: a histopathologic study. Trans Am Ophthalmol Soc 1977; 75:180-254. [PMID: 613523].
9. Sunness JS, Gonzalez-Baron J, Bressler NM, Hawkins B, Applegate CA. The development of choroidal neovascularization in eyes with the geographic atrophy form of age-related macular degeneration Ophthalmology 1999; 106:910-9. [PMID: 10328389].
10. Sohn EH, Khanna A, Tucker BA, Abramoff MD, Stone EM, Mullins RF. Structural and biochemical analyses of choroidal thickness in human donor eyes. Invest Ophthalmol Vis Sci 2014; 55:1352-60. [PMID: 24519422].
11. Sparrow JR, Ueda K, Zhou J. Complement dysregulation in AMD: RPE-Bruch’s membrane-choroid. Mol Aspects Med 2012; 33:436-45. [PMID: 22504022].
12. Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch’s membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 2001; 20:705-32. [PMID: 11587915].
13. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI, Hageman JL, Stockman HA, Borchardt JD, Gehrs KM, Smith RJ, Silvestri G, Russell SR, Klaver CC, Barbazetto I, Chang S, Yannuzzi LA, Barile GR, Merriam JC, Smith RT, Olsh AK, Bergeron J, Zernant J, Merriam JE, Gold B, Dean M, Allikmets R. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 2005; 102:7227-32. [PMID: 15870199].
14. Crabb JW, Miyagi M, Gu X, Shadrach K, West KA, Sakaguchi H, Kamei M, Hasan A, Yan L, Rayborn ME, Salomon RG, Hollyfield JG. Drusen proteome analysis: An approach to the etiology of age-related macular degeneration. Proceedings of the National Academy of Sciences 2002:222551899.
15. Curcio CA, Millican CL, Bailey T, Kruth HS. Accumulation of cholesterol with age in human Bruch’s membrane. Invest Ophthalmol Vis Sci 2001; 42:265-74. [PMID: 11133878].
16. Rodriguez IR, Clark ME, Lee JW, Curcio CA. 7-ketocholesterol accumulates in ocular tissues as a consequence of aging and is present in high levels in drusen. Exp Eye Res 2014; 128:151-5. [PMID: 25261634].
17. Handa JT, Verzijl N, Matsunaga H, Aotaki-Keen A, Lutty GA, te Koppele JM, Miyata T, Hjelmeland LM. Increase in the advanced glycation end product pentosidine in Bruch’s membrane with age. Invest Ophthalmol Vis Sci 1999; 40:775-9. [PMID: 10067983].
18. Spaide RF, Armstrong D, Browne R. Continuing medical education review: choroidal neovascularization in age-related macular degeneration-what is the cause? Retina 2003; 23:595-614. [PMID: 14574243].
19. Hartnett ME, Elsner AE. Characteristics of exudative age-related macular degeneration determined in vivo with confocal and indirect infrared imaging. Ophthalmology 1996; 103:58-71. [PMID: 8628562].
20. Bhutto I, Lutty G. Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch’s membrane/choriocapillaris complex. Mol Aspects Med 2012; 33:295-317. [PMID: 22542780].
21. McLeod DS, Grebe R, Bhutto I, Merges C, Baba T, Lutty GA. Relationship between RPE and choriocapillaris in age-related macular degeneration. Invest Ophthalmol Vis Sci 2009; 50:4982-91. [PMID: 19357355].
22. Grossniklaus HE, Gass JD. Clinicopathologic correlations of surgically excised type 1 and type 2 submacular choroidal neovascular membranes. Am J Ophthalmol 1998; 126:59-69. [PMID: 9683150].
23. Grossniklaus HE, Green WR. Choroidal neovascularization. Am J Ophthalmol 2004; 137:496-503. [PMID: 15013874].
24. Yannuzzi LA, Negrao S, Iida T, Carvalho C, Rodriguez-Coleman H, Slakter J, Freund KB, Sorenson J, Orlock D, Borodoker N. Retinal angiomatous proliferation in age-related macular degeneration. Retina 2001; 21:416-34. [PMID: 11642370].
25. Choi W, Moult EM, Waheed NK, Adhi M, Lee B, Lu CD, de Carlo TE, Jayaraman V, Rosenfeld PJ, Duker JS, Fujimoto JG. Ultrahigh-Speed, Swept-Source Optical Coherence Tomography Angiography in Nonexudative Age-Related Macular Degeneration with Geographic Atrophy. Ophthalmology 2015; 122:2532-44. [PMID: 26481819].
26. Rudnicka AR, Jarrar Z, Wormald R, Cook DG, Fletcher A, Owen CG. Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. Ophthalmology 2012; 119:571-80. [PMID: 22176800].
27. Sobrin L, Seddon JM. Nature and nurture-genes and environment-predict onset and progression of macular degeneration. Prog Retin Eye Res 2014; 40:1-15. [PMID: 24374240].
28. Toomey CB, Kelly U, Saban DR, Bowes Rickman C. Regulation of age-related macular degeneration-like pathology by complement factor H. Proc Natl Acad Sci USA 2015; 112:E3040-9. [PMID: 25991857].
29. Fritsche LG, Fariss RN, Stambolian D, Abecasis GR, Curcio CA, Swaroop A. Age-related macular degeneration: genetics and biology coming together. Annu Rev Genomics Hum Genet 2014; 15:151-71. [PMID: 24773320].
30. Seddon JM, Silver RE, Kwong M, Rosner B. Risk Prediction for Progression of Macular Degeneration: 10 Common and Rare Genetic Variants, Demographic, Environmental, and Macular Covariates. Invest Ophthalmol Vis Sci 2015; 56:2192-202. [PMID: 25655794].
31. Fujihara M, Nagai N, Sussan TE, Biswal S, Handa JT. Chronic Cigarette Smoke Causes Oxidative Damage and Apoptosis to Retinal Pigmented Epithelial Cells in Mice. PLoS One 2008; 3:e3119-[PMID: 18769672].
32. Espinosa-Heidmann DG, Suner IJ, Catanuto P, Hernandez EP, Marin-Castano ME, Cousins SW. Cigarette smoke-related oxidants and the development of sub-RPE deposits in an experimental animal model of dry AMD. Invest Ophthalmol Vis Sci 2006; 47:729-37. [PMID: 16431974].
33. Ramkumar HL, Zhang J, Chan CC. Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD). Prog Retin Eye Res 2010; 29:169-90. [PMID: 20206286].
34. Ambati J. Age-related macular degeneration and the other double helix. The Cogan Lecture. Invest Ophthalmol Vis Sci 2011; 52:2165-9. [PMID: 21471430].
35. Hirschi KK, Rohovsky SA, Beck LH, Smith SR, D’Amore PA. Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact. Circ Res 1999; 84:298-305. [PMID: 10024303].
36. Blasiak J, Petrovski G, Vereb Z, Facsko A, Kaarniranta K. Oxidative stress, hypoxia, and autophagy in the neovascular processes of age-related macular degeneration. BioMed Res Int 2014; 2014:768026-[PMID: 24707498].
37. Nussenblatt RB, Ferris F 3rd. Age-related macular degeneration and the immune response: implications for therapy. Am J Ophthalmol 2007; 144:618-26. [PMID: 17698021].
38. Mullins RF, Russell SR, Anderson DH, Hageman GS. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J 2000; 14:835-46. [PMID: 10783137].
39. Edwards MM, McLeod DS, Bhutto IA, Villalonga MB, Seddon JM, Lutty GA. Idiopathic preretinal glia in aging and age-related macular degeneration. Exp Eye Res 2015; [PMID: 26220834].
40. Zhang SX, Ma JH, Bhatta M, Fliesler SJ, Wang JJ. The unfolded protein response in retinal vascular diseases: implications and therapeutic potential beyond protein folding. Prog Retin Eye Res 2015; 45:111-31. [PMID: 25529848].
41. Mitter SK, Song C, Qi X, Mao H, Rao H, Akin D, Lewin A, Grant M, Dunn W Jr, Ding J, Bowes Rickman C, Boulton M. Dysregulated autophagy in the RPE is associated with increased susceptibility to oxidative stress and AMD. Autophagy 2014; 10:1989-2005. [PMID: 25484094].
42. Lin CH, Li CH, Liao PL, Tse LS, Huang WK, Cheng HW, Cheng YW. Silibinin inhibits VEGF secretion and age-related macular degeneration in a hypoxia-dependent manner through the PI-3 kinase/Akt/mTOR pathway. Br J Pharmacol 2013; 168:920-31. [PMID: 23004355].
43. Rodriguez IR, Larrayoz IM. Cholesterol oxidation in the retina: implications of 7KCh formation in chronic inflammation and age-related macular degeneration. J Lipid Res 2010; 51:2847-62. [PMID: 20567027].
44. Klettner A. Oxidative stress induced cellular signaling in RPE cells. Front Biosci (Schol Ed) 2012; 4:392-411. [PMID: 22202067].
45. Cai X, McGinnis JF. Oxidative stress: the achilles’ heel of neurodegenerative diseases of the retina. Front Biosci (Landmark Ed) 2012; 17:1976-95. [PMID: 22201850].
46. Indaram M, Ma W, Zhao L, Fariss RN, Rodriguez IR, Wong WT. 7-Ketocholesterol increases retinal microglial migration, activation, and angiogenicity: a potential pathogenic mechanism underlying age-related macular degeneration. Sci Rep 2015; 5:9144-[PMID: 25775051].
47. Sakurai E, Anand A, Ambati BK, van Rooijen N, Ambati J. Macrophage depletion inhibits experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 2003; 44:3578-85. [PMID: 12882810].
48. Terasaki H, Kase S, Shirasawa M, Otsuka H, Hisatomi T, Sonoda S, Ishida S, Ishibashi T, Sakamoto T. TNF-alpha decreases VEGF secretion in highly polarized RPE cells but increases it in non-polarized RPE cells related to crosstalk between JNK and NF-kappaB pathways. PLoS One 2013; 8:e69994-[PMID: 23922887].
49. Tuo J, Wang Y, Cheng R, Li Y, Chen M, Qiu F, Qian H, Shen D, Penalva R, Xu H, Ma JX, Chan CC. Wnt signaling in age-related macular degeneration: human macular tissue and mouse model. J Transl Med 2015; 13:330-[PMID: 26476672].
50. Hu Y, Chen Y, Lin M, Lee K, Mott RA, Ma JX. Pathogenic role of the Wnt signaling pathway activation in laser-induced choroidal neovascularization. Invest Ophthalmol Vis Sci 2013; 54:141-54. [PMID: 23211829].
51. Jaffe GJ, Eliott D, Wells JA, Prenner JL, Papp A, Patel S. A Phase 1 Study of Intravitreous E10030 in Combination with Ranibizumab in Neovascular Age-Related Macular Degeneration. Ophthalmology 2016; 123:78-85. [PMID: 26499921].
52. Radeke MJ, Radeke CM, Shih YH, Hu J, Bok D, Johnson LV, Coffey PJ. Restoration of mesenchymal retinal pigmented epithelial cells by TGFbeta pathway inhibitors: implications for age-related macular degeneration. Genome Med 2015; 7:58-[PMID: 26150894].
53. Takeda A, Baffi JZ, Kleinman ME, Cho WG, Nozaki M, Yamada K, Kaneko H, Albuquerque RJC, Dridi S, Saito K, Raisler BJ, Budd SJ, Geisen P, Munitz A, Ambati BK, Green MG, Ishibashi T, Wright JD, Humbles AA, Gerard CJ, Ogura Y, Pan Y, Smith JR, Grisanti S, Hartnett ME, Rothenberg ME, Ambati J. CCR3 is a target for age-related macular degeneration diagnosis and therapy. Nature 2009; 460:225-30. [PMID: 19525930].
54. de Oliveira Dias JR, Rodrigues EB, Maia M, Magalhaes O Jr, Penha FM, Farah ME. Cytokines in neovascular age-related macular degeneration: fundamentals of targeted combination therapy. Br J Ophthalmol 2011; 95:1631-7. [PMID: 21546514].
55. Fei P, Zaitoun I, Farnoodian M, Fisk DL, Wang S, Sorenson CM, Sheibani N. Expression of thrombospondin-1 modulates the angioinflammatory phenotype of choroidal endothelial cells. PLoS One 2014; 9:e116423-[PMID: 25548916].
56. Ildefonso CJ, Biswal MR, Ahmed CM, Lewin AS. The NLRP3 Inflammasome and its Role in Age-Related Macular Degeneration. Adv Exp Med Biol 2016; 854:59-65. [PMID: 26427394].
57. Gelfand BD, Wright CB, Kim Y, Yasuma T, Yasuma R, Li S, Fowler BJ, Bastos-Carvalho A, Kerur N, Uittenbogaard A, Han YS, Lou D, Kleinman ME, McDonald WH, Nunez G, Georgel P, Dunaief JL, Ambati J. Iron Toxicity in the Retina Requires Alu RNA and the NLRP3 Inflammasome. Cell Reports 2015; 11:1686-93. [PMID: 26074074].
58. Marneros AG. VEGF-A and the NLRP3 Inflammasome in Age-Related Macular Degeneration. Adv Exp Med Biol 2016; 854:79-85. [PMID: 26427397].
59. Saint-Geniez M, Kurihara T, Sekiyama E, Maldonado AE, D’Amore PA. An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris. Proc Natl Acad Sci USA 2009; 106:18751-6. [PMID: 19841260].
60. Saint-Geniez M, Maharaj AS, Walshe TE, Tucker BA, Sekiyama E, Kurihara T, Darland DC, Young MJ, D’Amore PA. Endogenous VEGF is required for visual function: evidence for a survival role on muller cells and photoreceptors. PLoS One 2008; 3:e3554-[PMID: 18978936].
61. Ford KM, Saint-Geniez M, Walshe T, Zahr A, D’Amore PA. Expression and Role of VEGF in the Adult Retinal Pigment Epithelium. Invest Ophthalmol Vis Sci 2011; 52:9478-87. [PMID: 22058334].
62. Maharaj ASR, Saint-Geniez M, Maldonado AE, D’Amore PA. Vascular Endothelial Growth Factor Localization in the Adult. Am J Pathol 2006; 168:639-48. [PMID: 16436677].
63. Saint-Geniez M, Maldonado AE, D’Amore PA. VEGF Expression and Receptor Activation in the Choroid during Development and in the Adult. Invest Ophthalmol Vis Sci 2006; 47:3135-42. [PMID: 16799060].
64. Henkind P, Gartner S. The relationship between retinal pigment epithelium and the choriocapillaris. Trans Ophthalmol Soc U K 1983; 103:444-7. [PMID: 6589861].
65. Korte GE, Reppucci V, Henkind P. RPE destruction causes choriocapillary atrophy. Invest Ophthalmol Vis Sci 1984; 25:1135-45. [PMID: 6480292].
66. Geltzer A, Turalba A, Vedula SS. Surgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degeneration. Cochrane Database Syst Rev 2013; 1:CD005022-[PMID: 23440797].
67. Gehrs KM, Anderson DH, Johnson LV, Hageman GS. Age-related macular degeneration merging pathogenetic and therapeutic concepts. Ann Med 2006; 38:450-71. [PMID: 17101537].
68. Wykoff CC, Croft DE, Brown DM, Wang R, Payne JF, Clark L, Abdelfattah NS, Sadda SR. Prospective Trial of Treat-and-Extend versus Monthly Dosing for Neovascular Age-Related Macular Degeneration: TREX-AMD 1-Year Results. Ophthalmology 2015; 122:2514-22. [PMID: 26391465].
69. Scott AW, Bressler SB. Long-term follow-up of vascular endothelial growth factor inhibitor therapy for neovascular age-related macular degeneration. Curr Opin Ophthalmol 2013; 24:190-6. [PMID: 23492430].
70. Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR. Group. tVISiONCT: Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004; 351:2805-16. [PMID: 15625332].
71. Chakravarthy U, Harding SP, Rogers CA, Downes S, Lotery AJ, Dakin HA, Culliford L, Scott LJ, Nash RL, Taylor J, Muldrew A, Sahni J, Wordsworth S, Raftery J, Peto T, Reeves BC. A randomised controlled trial to assess the clinical effectiveness and cost-effectiveness of alternative treatments to Inhibit VEGF in Age-related choroidal Neovascularisation (IVAN). Health Technol Assess 2015; 19:1-298. [PMID: 26445075].
72. Bhisitkul RB, Mendes TS, Rofagha S, Enanoria W, Boyer DS, Sadda SR, Zhang K. Macular atrophy progression and 7-year vision outcomes in subjects from the ANCHOR, MARINA, and HORIZON studies: the SEVEN-UP study. Am J Ophthalmol 2015; 159:915-24. [PMID: 25640411].
73. Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 2011; 364:1897-908. [PMID: 21526923].
74. Ying GS, Huang J, Maguire MG, Jaffe GJ, Grunwald JE, Toth C, Daniel E, Klein M, Pieramici D, Wells J, Martin DF. Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration. Ophthalmology 2013; 120:122-9. [PMID: 23047002].
75. Young M, Chui L, Fallah N, Or C, Merkur AB, Kirker AW, Albiani DA, Forooghian F. Exacerbation of choroidal and retinal pigment epithelial atrophy after anti-vascular endothelial growth factor treatment in neovascular age-related macular degeneration. Retina 2014; 34:1308-15. [PMID: 24451923].
76. Singh RS, Kim JE. Ocular hypertension following intravitreal anti-vascular endothelial growth factor agents. Drugs Aging 2012; 29:949-56. [PMID: 23179897].
77. Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study. Macular Photocoagulation Study Group. Arch Ophthalmol 1991; 109:1242-57. [PMID: 1718252].
78. Singerman LJ, Stockfish JH. Natural history of subfoveal pigment epithelial detachments associated with subfoveal or unidentifiable choroidal neovascularization complicating age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 1989; 227:501-7. [PMID: 2483142].
79. Lukason M, DuFresne E, Rubin H, Pechan P, Li Q, Kim I, Kiss S, Flaxel C, Collins M, Miller J, Hauswirth W, Maclachlan T, Wadsworth S, Scaria A. Inhibition of choroidal neovascularization in a nonhuman primate model by intravitreal administration of an AAV2 vector expressing a novel anti-VEGF molecule. Mol Ther 2011; 19:260-5. [PMID: 20978476].
80. Coscas GJ, Lupidi M, Coscas F, Cagini C, Souied EH. Optical coherence tomography angiography versus traditional multimodal imaging in assessing the activity of exudative age-related macular generation: A New Diagnostic Challenge. Retina 2015; 35:2219-28. [PMID: 26398697].
81. Stevens TS, Bressler NM, Maguire MG, Bressler SB, Fine SL, Alexander J, Phillips DA, Margherio RR, Murphy PL, Schachat AP. Occult choroidal neovascularization in age-related macular degeneration. A natural history study. Arch Ophthalmol 1997; 115:345-50. [PMID: 9076206].
82. Hartnett ME, Weiter JJ, Staurenghi G, Elsner AE. Deep retinal vascular anomalous complexes in advanced age-related macular degeneration. Ophthalmology 1996; 103:2042-53. [PMID: 9003338].
83. Parravano M, Pilotto E, Musicco I, Varano M, Introini U, Staurenghi G, Menchini U, Virgili G. Reproducibility of fluorescein and indocyanine green angiographic assessment for RAP diagnosis: a multicenter study. Eur J Ophthalmol 2012; 22:598-606. [PMID: 22139618].
84. Kuehlewein L, Dansingani KK, de Carlo TE, Bonini Filho MA, Iafe NA, Lenis TL, Freund KB, Waheed NK, Duker JS, Sadda SR, Sarraf D. Optical Coherence Tomography Angiography of Type 3 Neovascularization Secondary to Age-Related Macular Degeneration. Retina 2015; 35:2229-35. [PMID: 26502007].
85. Ueda-Arakawa N, Ooto S, Nakata I, Yamashiro K, Tsujikawa A, Oishi A, Yoshimura N. Prevalence and genomic association of reticular pseudodrusen in age-related macular degeneration. Am J Ophthalmol 2013; 155:260-9. [PMID: 23111182].
86. Arnold JJ, Sarks SH, Killingsworth MC, Sarks JP. Reticular pseudodrusen. A risk factor in age-related maculopathy. Retina 1995; 15:183-91. [PMID: 7569344].
87. Cho HJ, Yoo SG, Kim HS, Kim JH, Kim CG, Lee TG, Kim JW. Risk factors for geographic atrophy after intravitreal ranibizumab injections for retinal angiomatous proliferation. Am J Ophthalmol 2015; 159:285-92. [PMID: 25447115].
88. Hirschi KK, Rohovsky SA, D’Amore PA. Cell-cell interactions in vessel assembly: a model for the fundamentals of vascular remodelling. Review. 5 refs. Transpl Immunol 1997; 5:177-8. [PMID: 9402682].
89. Geisen P, McColm JR, Hartnett ME. Choroidal endothelial cells transmigrate across the retinal pigment epithelium but do not proliferate in response to soluble vascular endothelial growth factor. Exp Eye Res 2006; 82:608-19. [PMID: 16259980].
90. Wang H, Geisen P, Wittchen ES, King B, Burridge K, D’Amore PA, Hartnett ME. The Role of RPE Cell-Associated VEGF189 in Choroidal Endothelial Cell Transmigration across the RPE. Invest Ophthalmol Vis Sci 2011; 52:570-8. [PMID: 20811045].
91. Peterson LJ, Wittchen ES, Geisen P, Burridge K, Hartnett ME. Heterotypic RPE-choroidal endothelial cell contact increases choroidal endothelial cell transmigration via PI 3-kinase and Rac1. Exp Eye Res 2007; 84:737-44. [PMID: 17292356].
92. Garrett TA, Van Buul JD, Burridge K. VEGF-induced Rac1 activation in endothelial cells is regulated by the guanine nucleotide exchange factor Vav2. Exp Cell Res 2007; 313:3285-97. [PMID: 17686471].
93. Wang H, Wittchen ES, Jiang Y, Ambati B, Grossniklaus HE, Hartnett ME. Upregulation of CCR3 by Age-Related Stresses Promotes Choroidal Endothelial Cell Migration via VEGF-Dependent and-Independent Signaling. Invest Ophthalmol Vis Sci 2011; 52:8271-7. [PMID: 21917937].
94. Giehl K, Graness A, Goppelt-Struebe M. The small GTPase Rac-1 is a regulator of mesangial cell morphology and thrombospondin-1 expression. Am J Physiol Renal Physiol 2008; 294:F407-13. [PMID: 18045834].
95. Chen Y, Zhong M, Liang L, Gu F, Peng H. Interleukin-17 induces angiogenesis in human choroidal endothelial cells in vitro. Invest Ophthalmol Vis Sci 2014; 55:6968-75. [PMID: 25228547].
96. Bid HK, Roberts RD, Manchanda PK, Houghton PJ. RAC1: an emerging therapeutic option for targeting cancer angiogenesis and metastasis. Mol Cancer Ther 2013; 12:1925-34. [PMID: 24072884].
97. Ushio-Fukai M. VEGF Signaling Through NADPH Oxidase-Derived ROS. Antioxid Redox Signal 2007; 9:731-9. [PMID: 17511588].
98. Ushio-Fukai M, Alexander RW. Reactive oxygen species as mediators of angiogenesis signaling. Role of NAD(P)H oxidase. Mol Cell Biochem 2004; V264:85-97. [PMID: 15544038].
99. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS Report No. 8. Arch Ophthalmol 2001; 119:1417-36. [PMID: 11594942].
100. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA 2013; 309:2005-15. [PMID: 23644932].
101. Monaghan-Benson E, Hartmann J, Vendrov AE, Budd S, Byfield G, Parker A, Ahmad F, Huang W, Runge M, Burridge K, Madamanchi N, Hartnett ME. The Role of Vascular Endothelial Growth Factor-Induced Activation of NADPH Oxidase in Choroidal Endothelial Cells and Choroidal Neovascularization. Am J Pathol 2010; 177:2091-102. [PMID: 20802176].
102. Xu H, Chen M, Forrester JV. Para-inflammation in the aging retina. Prog Retin Eye Res 2009; 28:348-68. [PMID: 19560552].
103. Rodrigues MM, Wiggert B, T’so MM, Chader GJ. Retinitis pigmentosa: Immunohistochemical and biochemical studies of the retina. Can J Ophthalmol 1986; 21:[PMID: 3085907].
104. Wang H, Fotheringham L, Wittchen ES, Hartnett ME. Rap1 GTPase Inhibits Tumor Necrosis Factor-alpha-Induced Choroidal Endothelial Migration via NADPH Oxidase-and NF-kappaB-Dependent Activation of Rac1. Am J Pathol 2015; 185:3316-25. [PMID: 26476350].
105. Wittchen ES, Aghajanian A, Burridge K. Isoform-specific differences between Rap1A and Rap1B GTPases in the formation of endothelial cell junctions. Small GTPases 2011; 2:65-76. [PMID: 21776404].
106. Wilson CW, Ye W. Regulation of vascular endothelial junction stability and remodeling through Rap1-Rasip1 signaling. Cell Adhes Migr 2014; 8:76-83. [PMID: 24622510].
107. Wittchen ES, Nishimura E, McCloskey M, Wang H, Quilliam LA, Chrzanowska-Wodnicka M, Hartnett ME. Rap1 GTPase activation and barrier enhancement in rpe inhibits choroidal neovascularization in vivo. PLoS One 2013; 8:e73070-[PMID: 24039860].
108. Chrzanowska-Wodnicka M, Kraus AE, Gale D, White GC 2nd, Vansluys J. Defective angiogenesis, endothelial migration, proliferation, and MAPK signaling in Rap1b-deficient mice. Blood 2008; 111:2647-56. [PMID: 17993608].
109. Wang H, Jiang Y, Shi D, Quilliam LA, Chrzanowska-Wodnicka M, Wittchen ES, Li DY, Hartnett ME. Activation of Rap1 inhibits NADPH oxidase-dependent ROS generation in retinal pigment epithelium and reduces choroidal neovascularization. FASEB J 2014; 28:265-74. [PMID: 24043260].
110. Zhou T, Hu Y, Chen Y, Zhou KK, Zhang B, Gao G, Ma JX. The pathogenic role of the canonical Wnt pathway in age-related macular degeneration. Invest Ophthalmol Vis Sci 2010; 51:4371-9. [PMID: 19875668].
111. Seddon JM, Willett WC, Speizer FE, Hankinson SE. A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA 1996; 276:1141-6. [PMID: 8827966].
112. Fliesler SJ. Cholesterol homeostasis in the retina: seeing is believing. J Lipid Res 2015; 56:1-4. [PMID: 25421059].
113. Amaral J, Lee JW, Chou J, Campos MM, Rodriguez IR. 7-Ketocholesterol induces inflammation and angiogenesis in vivo: a novel rat model. PLoS One 2013; 8:e56099-[PMID: 23409131].
114. Blaauwgeers HGT, Holtkamp GM, Rutten H, Witmer AN, Koolwijk P, Partanen TA, Alitalo K, Kroon ME, Kijlstra A, van Hinsbergh VWM, Schlingemann RO. Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris: evidence for a trophic paracrine relation. Am J Pathol 1999; 155:421-8. [PMID: 10433935].
115. Poltorak Z, Cohen T, Sivan R, Kandelis Y, Spira G, Vlodavsky I, Keshet E, Neufeld G. VEGF145, a Secreted Vascular Endothelial Growth Factor Isoform That Binds to Extracellular Matrix. J Biol Chem 1997; 272:7151-8. [PMID: 9054410].